AstraZeneca succeeds in treating late-stage lupus in new study

Yahoo News Video

The drugmaker AstraZeneca said on Monday its experimental treatment significantly reduced disease activity in patients with the autoimmune disorder lupus in a late-stage study.

What to Read Next